EP 1990420 B1 20100811 - Method for the detection of the in-vivo activity of neurotrypsin, use of the method and use of the C-terminal 22-kDa fragment of agrin as biomarker in diagnosis and monitoring of neurotrypsin-related disturbances
Title (en)
Method for the detection of the in-vivo activity of neurotrypsin, use of the method and use of the C-terminal 22-kDa fragment of agrin as biomarker in diagnosis and monitoring of neurotrypsin-related disturbances
Title (de)
Verfahren zur Detektion der in-vivo-Aktivität von Neurotrypsin, Verwendung des Verfahrens und Verwendung des C-terminal 22-kDa-Fragments als Biomarker bei der Diagnose und Überwachung von Störungen im Zusammenhang mit Neurotrypsin
Title (fr)
Procédé de détection d'une activité in-vivo de neurotrypsine, utilisation du procédé et utilisation du fragment 22-kDa du terminal C d'agrine comme un biomarqueur dans le diagnostic et la surveillance des perturbations liées à la neurotrypsine
Publication
Application
Priority
EP 07009398 A 20070510
Abstract (en)
[origin: EP1990420A1] Method for the detection of the in-vivo activity of neurotrypsin wherein the amount of the 22-kDa-fragment of agrin is measured in a sample taken from a patient and the measured amount of the 22-kDa-fragment of agrin in the sample is used to calculate the activity of neurotrypsin, use of the method for diagnosis and monitoring of neurotrypsin-related disturbances and use of the 22-kDa-fragment of agrin as biomarker for neurotrypsin-related disturbances.
IPC 8 full level
C12Q 1/37 (2006.01)
CPC (source: EP US)
C12Q 1/37 (2013.01 - EP US); G01N 2333/811 (2013.01 - EP US); G01N 2800/12 (2013.01 - EP US); G01N 2800/28 (2013.01 - EP US); G01N 2800/347 (2013.01 - EP US)
Citation (examination)
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; October 2005 (2005-10-01), THADIKKARAN LYNNE ET AL: "The role of proteomics in the assessment of premature rupture of fetal membranes.", Database accession no. NLM15970282 & CLINICA CHIMICA ACTA; INTERNATIONAL JOURNAL OF CLINICAL CHEMISTRY OCT 2005, vol. 360, no. 1-2, October 2005 (2005-10-01), pages 27 - 36, ISSN: 0009-8981
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
EP 1990420 A1 20081112; EP 1990420 B1 20100811; AT E477329 T1 20100815; AU 2008250733 A1 20081120; BR PI0811429 A2 20160517; CA 2692132 A1 20081120; CN 101680022 A 20100324; CY 1111602 T1 20151007; DE 602007008370 D1 20100923; DK 1990420 T3 20101115; ES 2350254 T3 20110120; JP 2010526994 A 20100805; PL 1990420 T3 20110131; PT 1990420 E 20101104; SI 1990420 T1 20101231; US 2010240083 A1 20100923; WO 2008138474 A1 20081120
DOCDB simple family (application)
EP 07009398 A 20070510; AT 07009398 T 20070510; AU 2008250733 A 20080426; BR PI0811429 A 20080426; CA 2692132 A 20080426; CN 200880015511 A 20080426; CY 101101006 T 20101108; DE 602007008370 T 20070510; DK 07009398 T 20070510; EP 2008003406 W 20080426; ES 07009398 T 20070510; JP 2010506829 A 20080426; PL 07009398 T 20070510; PT 07009398 T 20070510; SI 200730401 T 20070510; US 59945608 A 20080426